Immune checkpoint blockade is more effective in a syngeneic mouse model of melanoma deficient in Chd1 and Map3k7 and is associated with elevated intra-tumoral CD8<sup>+</sup> T cell numbers and activation. The gene discussed is CHD1; the disease is melanoma.